Drug-Coated Balloons: Current Outcomes and Future Directions

Ananya Kondapalli; Barbara A. Danek; Houman Khalili; Haekyung Jeon-Slaughter; Subhash Banerjee

doi:10.1016/j.iccl.2016.12.005

Drug-Coated Balloons: Current Outcomes and Future Directions

Ananya Kondapalli, Barbara A. Danek, Houman Khalili, Haekyung Jeon-Slaughter, Subhash Banerjee

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

Original language	English (US)
Pages (from-to)	217-225
Number of pages	9
Journal	Interventional Cardiology Clinics
Volume	6
Issue number	2
DOIs	https://doi.org/10.1016/j.iccl.2016.12.005
State	Published - Apr 1 2017

Keywords

Drug-coated balloons
Endovascular intervention
Femoropopliteal peripheral artery
Infrapopliteal peripheral artery
Paclitaxel

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.iccl.2016.12.005

Cite this

@article{9563123564d34205bde2b5bfedcf26f7,

title = "Drug-Coated Balloons: Current Outcomes and Future Directions",

abstract = "Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.",

keywords = "Drug-coated balloons, Endovascular intervention, Femoropopliteal peripheral artery, Infrapopliteal peripheral artery, Paclitaxel",

author = "Ananya Kondapalli and Danek, {Barbara A.} and Houman Khalili and Haekyung Jeon-Slaughter and Subhash Banerjee",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.iccl.2016.12.005",

language = "English (US)",

volume = "6",

pages = "217--225",

journal = "Interventional Cardiology Clinics",

issn = "2211-7458",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Drug-Coated Balloons

T2 - Current Outcomes and Future Directions

AU - Kondapalli, Ananya

AU - Danek, Barbara A.

AU - Khalili, Houman

AU - Jeon-Slaughter, Haekyung

AU - Banerjee, Subhash

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

AB - Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

KW - Drug-coated balloons

KW - Endovascular intervention

KW - Femoropopliteal peripheral artery

KW - Infrapopliteal peripheral artery

KW - Paclitaxel

UR - http://www.scopus.com/inward/record.url?scp=85009496035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009496035&partnerID=8YFLogxK

U2 - 10.1016/j.iccl.2016.12.005

DO - 10.1016/j.iccl.2016.12.005

M3 - Review article

C2 - 28257769

AN - SCOPUS:85009496035

SN - 2211-7458

VL - 6

SP - 217

EP - 225

JO - Interventional Cardiology Clinics

JF - Interventional Cardiology Clinics

IS - 2

ER -

Drug-Coated Balloons: Current Outcomes and Future Directions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this